DSHB

BCL2 like 1 antibody - Clinical Proteomics Technologies for Cancer; National Cancer Institute

#CPTC-BCL2L1-1 · western blot

1
Citing papers
0
Combined citations
Supplier page Find this product

Research areas

Barrier Structure and Function Studies1Endoplasmic Reticulum Stress and Disease1Parkinson's Disease Mechanisms and Treatments1

Papers citing this product

1
Systematic screening identifies elevated neurovascular BCL-XL in Parkinson’s disease
bioRxiv (Cold Spring Harbor Laboratory)·2026·DOI

Also available from other vendors

This target has 177 citing papers across all vendors combined

VendorProductPricePapers
Leica BiosystemsAnti-bcl-2 Oncoprotein Monoclonal Antibody, Unconjugated—1
Leica BiosystemsAnti-bcl-2 Oncoprotein Monoclonal Antibody, Unconjugated—16
Leica BiosystemsAnti-bcl-2 Oncoprotein Monoclonal Antibody, Unconjugated—2
Leica BiosystemsAnti-bcl-2 Oncoprotein Monoclonal Antibody, Unconjugated—6
DSHBBCL2-like 2 antibody - Clinical Proteomics Technologies for Cancer; National Cancer Institute—157
DSHBBCL2-like 2 antibody - Clinical Proteomics Technologies for Cancer; National Cancer Institute—157
DSHBBCL2 like 1 antibody - Clinical Proteomics Technologies for Cancer; National Cancer Institute—157
DSHBBCL2 like 1 antibody - Clinical Proteomics Technologies for Cancer; National Cancer Institute—157
DSHBBCL2-like 2 antibody - Clinical Proteomics Technologies for Cancer; National Cancer Institute—157

Similar products

ProductVendorPricePapers
BCL2 like 1 antibody - Clinical Proteomics Technologies for Cancer; National Cancer InstituteMouseDSHB—157
BCL2 like 1 antibody - Clinical Proteomics Technologies for Cancer; National Cancer InstituteMouseDSHB—157